Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (8): 1299-1303.doi: 10.16352/j.issn.1001-6325.2023.08.1299

• Mini Reviews • Previous Articles     Next Articles

Research advances of Ghrelin in metabolic diseases

WANG Xinrui, QIN Yan*   

  1. Department of Physiology and Pathophysiology, School of Basic Medicine, Dali University, Dali 671000, China
  • Received:2022-07-21 Revised:2022-12-04 Online:2023-08-05 Published:2023-07-26
  • Contact: *lantingxun@126.com

Abstract: Ghrelin, a newly discovered gastric peptide, involves in the regulation of various biological processes and plays important role in the occurrence and development of metabolic diseases such as non-alcoholic fatty liver disease, diabetes and obesity by effectively regulating glucose and lipid metabolism and anti-oxidation.

Key words: Ghrelin, non-alcoholic fatty liver disease, diabetes, obesity

CLC Number: